Analysts Are Bullish on These Healthcare Stocks: Evolus Inc (EOLS), Zogenix (ZGNX)


There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Evolus Inc (EOLS) and Zogenix (ZGNX) with bullish sentiments.

Evolus Inc (EOLS)

In a report released today, Irina Rivkind Koffler from Mizuho Securities reiterated a Buy rating on Evolus Inc, with a price target of $31. The company’s shares closed yesterday at $24.35.

Rivkind Koffler commented:

“We were not disappointed by the company’s Analyst Day, which offered further confirmation of our thesis. One really favorable surprise was how rapidly Evolus has managed to sign up willing physician customers, which leads us to believe we may be underestimating the speed of the ramp curve for the product. We remain conservative for now until we get more evidence of pull-through. We reiterate our Buy rating and $31 PT.”

According to TipRanks.com, Koffler is a 3-star analyst with an average return of 1.5% and a 41.2% success rate. Koffler covers the Healthcare sector, focusing on stocks such as Teva Pharmaceutical Industries Limited, Bausch Health Companies Inc, and Assertio Therapeutics Inc.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Evolus Inc with a $33.60 average price target, a 38.0% upside from current levels. In a report issued on April 26, Cantor Fitzgerald also reiterated a Buy rating on the stock with a $35 price target.

See today’s analyst top recommended stocks >>

Zogenix (ZGNX)

Mizuho Securities analyst Difei Yang maintained a Buy rating on Zogenix today and set a price target of $58. The company’s shares closed yesterday at $38.19, close to its 52-week low of $33.43.

According to TipRanks.com, Yang is a 5-star analyst with an average return of 11.5% and a 44.2% success rate. Yang covers the Healthcare sector, focusing on stocks such as Nightstar Therapeutics Limited, Xeris Pharmaceuticals Inc, and Alder Biopharmaceuticals.

Currently, the analyst consensus on Zogenix is a Strong Buy with an average price target of $56.57.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on ZGNX:

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts